Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy.
Sign Up to like & getrecommendations! Published in 2020 at "European urology oncology"
DOI: 10.1016/j.euo.2020.12.007
Abstract: CONTEXT Bladder urothelial carcinoma (BUC) and upper tract urothelial carcinoma (UTUC) have genetic differences, which may influence therapy. OBJECTIVE The aim of the current review was to summarize the current genetic understanding of upper tract… read more here.
Keywords: buc; carcinoma; genetic differences; upper urinary ... See more keywords
Three coordination compounds based on tris(1-imidazolyl)benzene: Hydrothermal synthesis, crystal structure and adsorption performances toward organic dyes
Sign Up to like & getrecommendations! Published in 2018 at "Polyhedron"
DOI: 10.1016/j.poly.2017.10.011
Abstract: Abstract Three coordination compounds, zero-dimensional Co(tib)(ADC)2 (BUC-60), one-dimensional Zn3(tib)2Cl6 (BUC-61) and three-dimensional [Cu2(tib)2(MoO4)Cl]Cl (BUC-62), were obtained from the reaction of 1,3,5-tris(1-imidazolyl)benzene (tib), 1,3-adamantanedicarboxylic acid (H2adc), phosphomolybdic acid hydrate (H3PO4ยท12MoO3) and the corresponding metal salts under… read more here.
Keywords: coordination compounds; buc; adsorption; three coordination ... See more keywords
Photocatalytic Cr(VI) elimination over BUC-21/N-K2Ti4O9 composites: Big differences in performance resulting from small differences in composition
Sign Up to like & getrecommendations! Published in 2021 at "Chinese Journal of Catalysis"
DOI: 10.1016/s1872-2067(20)63629-4
Abstract: Abstract A series of BUC-21/N-K2Ti4O9 composites (B1NX) were facilely fabricated from BUC-21 and N-K2Ti4O9 via ball-milling, and they were fully characterized using various techniques. The photocatalytic reduction of Cr(VI) over the B1NX composites was investigated… read more here.
Keywords: buc; k2ti4o9 composites; buc k2ti4o9; photocatalytic reduction ... See more keywords
SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival
Sign Up to like & getrecommendations! Published in 2018 at "Oncogene"
DOI: 10.1038/s41388-018-0223-2
Abstract: Sperm-associated antigen 5 (SPAG5) is involved in various biological processes. However, the roles of SPAG5 in bladder urothelial carcinoma (BUC) are unknown. This study showed that upregulation of SPAG5 was detected frequently in primary BUC… read more here.
Keywords: buc; bladder urothelial; spag5; urothelial carcinoma ... See more keywords
Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma via Inhibition of KLF9
Sign Up to like & getrecommendations! Published in 2022 at "Computational and Mathematical Methods in Medicine"
DOI: 10.1155/2022/8911343
Abstract: We focused on studying the effects of a key miRNA-mRNA axis in bladder urothelial carcinoma (BUC). Firstly, miRNAs and mRNAs differentially expressed in BUC were analyzed. Clinical information in the TCGA database was used for… read more here.
Keywords: bladder urothelial; overexpression; buc; urothelial carcinoma ... See more keywords
Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2024 at "BMC Medical Imaging"
DOI: 10.1186/s12880-024-01199-3
Abstract: Purpose To explore the application of contrast-enhanced ultrasound (CEUS) for the diagnosis and grading of bladder urothelial carcinoma (BUC). Methods The results of a two-dimensional ultrasound, color Doppler ultrasound and CEUS, were analyzed in 173… read more here.
Keywords: buc; intensity; application contrast; contrast ... See more keywords
Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2024 at "BMC Urology"
DOI: 10.1186/s12894-024-01466-z
Abstract: Objective To investigate the diagnostic value of urine cyclic RNA-0071196 (circRNA-0071196) in the patients with bladder urothelial carcinoma (BUC). Method The expression of circRNA-0071196 was detected in the urine samples using qRT-PCR from 40 BUC… read more here.
Keywords: buc; circrna 0071196; diagnostic value; expression circrna ... See more keywords
A novel risk score model based on five angiogenesis-related long non-coding RNAs for bladder urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Cell International"
DOI: 10.1186/s12935-022-02575-1
Abstract: Background Tumour angiogenesis is an independent risk factor for bladder urothelial carcinoma (BUC) progression, but viable and promising antiangiogenic targets are understudied. Emerging evidence suggests that long non-coding RNAs (lncRNAs) play prominent role in the… read more here.
Keywords: buc; risk; urothelial carcinoma; bladder urothelial ... See more keywords
Genomic analysis of same-patient metachronous upper-tract and bladder urothelial carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.6_suppl.449
Abstract: 449Background: Despite similarities between upper-tract (UTUC) and bladder urothelial carcinoma (BUC), distinctive clinicopathologic and genomic differences are being described. We further investigate the genomic landscape of these two interrelated malignancies in same-patient metachronous (m) UTUC… read more here.
Keywords: buc; patient metachronous; bladder urothelial; upper tract ... See more keywords
Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23126516
Abstract: The tight junction (TJ) protein claudin-4 (CLDN4) is overexpressed in bladder urothelial carcinoma (BUC) and correlates with cancer progression. However, the mechanism of CLDN4 upregulation and promotion of malignant phenotype is not clear. Here, we… read more here.
Keywords: promoter; buc; bladder; cldn4 ... See more keywords
Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.
Sign Up to like & getrecommendations! Published in 2018 at "Oncology letters"
DOI: 10.3892/ol.2017.7344
Abstract: Checkpoint kinase 1 (CHK1) and p53 are involved in cell-cycle checkpoint, and cellular response to DNA damage. CHK1 and p53 are overexpressed in bladder urothelial carcinoma (BUC); however, a clear elucidation on their interaction and… read more here.
Keywords: chk1 p53; buc; bladder urothelial; therapeutic targets ... See more keywords